Innovation & IP Asset Consulting
Convergence for divergent trends

Our client PRONIA develops a personalised prognostic tool for early psychosis management

Bildschirmfoto 2016-01-18 um 08.52.34 Psychoses typically commence in the most productive and critical period of life – late adolescence and early adulthood. In around 75-90 percent of the persons who develop the full-blown illness, there are early symptoms like lacking concentration, mood swings, exhaustion and reduced performance. To date, it is hard to say, whether such a psychological crisis will develop into a psychotic disorder. This is where the European research project PRONIA sets in. The aim of the researchers from five European countries and Australia is to develop an innovative prognostic tool on the basis of self-learning algorithms.

1700 study participants are being recruited for PRONIA in six European centres and one in Australia. PRONIA is aiming to raise the prognostic certainty for identifying future disease development to up to 90 percent. As a telemedicine application, PRONIA should be commercially available for medical practitioners and hospitals within the next five years.

The European Union has awarded PRONIA with 6 Million Euro within the 7th Framework Programme. The coordinator of the PRONIA project is PD Dr. Nikolaos Koutsouleris from the Psychiatric Clinic of the Ludwig-Maximilians-University in Munich. The study started on October 1st 2013 and will go on until October 2018.

Stellbrink IP and Arnason Stellbrink are pleased to be a part of that revolution and are very happy about the rising success of their client.

Find out more here.